Cita APA

Pierone, G., Schulman, K., Fusco, J. S., Vannappagari, V., Aboud, M., Ragone, L., & Fusco, G. (2019). 2483. Characteristics and Outcomes Over First 12 Months of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of HIV-1 in the United States. Open Forum Infect Dis.

Citación estilo Chicago

Pierone, Gerald, Kathy Schulman, Jennifer S. Fusco, Vani Vannappagari, Michael Aboud, Leigh Ragone, y Gregory Fusco. "2483. Characteristics and Outcomes Over First 12 Months of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of HIV-1 in the United States." Open Forum Infect Dis 2019.

Cita MLA

Pierone, Gerald, et al. "2483. Characteristics and Outcomes Over First 12 Months of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of HIV-1 in the United States." Open Forum Infect Dis 2019.